Final Diagnosis: Infective Endocarditis Due to Granulicatella adiacens and Streptococcus mitis.
Toni Campanella, PharmD*
Advertisement
Articles by Toni Campanella, PharmD*
The US Food and Drug Administration approved imipenem-cilastatin-relebactam to treat complicated intra-abdominal infections and complicated urinary tract infections in adults with limited treatment options.
Advertisement
Latest Updated Articles
- Imipenem-Cilastatin-Relebactam: Imipenem Is Rele Back Again
Published: February 13th 2020 | Updated:
- COVID-19 Complicates an Already Difficult Presentation of Infective Endocarditis
Published: June 17th 2020 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
2
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
3
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
4
Lori Handy, MD, MSCE, Discusses New Era of Dynamic, Trust-Based Health Communication
5
